NISA INVESTMENT ADVISORS, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$634,000
-19.4%
3,686
-41.2%
0.00%
-20.0%
Q2 2021$787,000
-7.4%
6,2680.0%0.01%0.0%
Q1 2021$850,000
+11.3%
6,268
+5.0%
0.01%0.0%
Q4 2020$764,000
+82.3%
5,968
+60.2%
0.01%
+66.7%
Q3 2020$419,000
+22.9%
3,726
+4.2%
0.00%0.0%
Q2 2020$341,000
+196.5%
3,576
+178.3%
0.00%
+200.0%
Q1 2020$115,000
+35.3%
1,285
-19.9%
0.00%0.0%
Q4 2019$85,000
-50.0%
1,605
-62.7%
0.00%
-50.0%
Q3 2019$170,000
+1788.9%
4,300
+1947.6%
0.00%
Q2 2019$9,000
-10.0%
2100.0%0.00%
Q1 2019$10,000
+11.1%
2100.0%0.00%
Q4 2018$9,000
-25.0%
2100.0%0.00%
Q3 2018$12,000
+20.0%
2100.0%0.00%
Q2 2018$10,000
+25.0%
2100.0%0.00%
Q1 2018$8,000
-46.7%
210
-41.7%
0.00%
Q4 2017$15,000
+15.4%
3600.0%0.00%
Q3 2017$13,000
+18.2%
3600.0%0.00%
Q2 2017$11,000
+83.3%
360
+71.4%
0.00%
Q1 2017$6,000
-40.0%
210
-47.5%
0.00%
Q4 2016$10,0004000.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 917,767$52,524,0008.19%
Foresite Capital Management II, LLC 220,268$12,606,0004.66%
Foresite Capital Management III, LLC 250,863$14,357,0003.17%
Novo Holdings A/S 650,000$37,200,0002.95%
QVT Financial LP 190,977$10,930,0002.82%
Perceptive Advisors 1,528,205$87,459,0002.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,117,651$63,963,0002.29%
Asymmetry Capital Management, L.P. 39,912$2,284,0002.11%
SECTORAL ASSET MANAGEMENT INC 298,726$17,096,0001.82%
Stanley-Laman Group, Ltd. 125,020$7,155,0001.76%
View complete list of ACCELERON PHARMA INC shareholders